International Journal of Biological Markers最新文献

筛选
英文 中文
Exploring key biomarkers associated with axillary lymph node metastasis in breast cancer using single-cell RNA sequencing and Mendelian randomization. 利用单细胞RNA测序和孟德尔随机化技术探索乳腺癌腋窝淋巴结转移相关的关键生物标志物。
IF 2 4区 医学
International Journal of Biological Markers Pub Date : 2026-05-12 DOI: 10.1177/03936155261443650
Limeng Qu, Jinyang Li, Shirong Ding, Qian Long, Wenjun Yi
{"title":"Exploring key biomarkers associated with axillary lymph node metastasis in breast cancer using single-cell RNA sequencing and Mendelian randomization.","authors":"Limeng Qu, Jinyang Li, Shirong Ding, Qian Long, Wenjun Yi","doi":"10.1177/03936155261443650","DOIUrl":"https://doi.org/10.1177/03936155261443650","url":null,"abstract":"<p><p>BackgroundAxillary lymph node metastasis (ALNM) serves as a critical prognostic determinant in breast cancer, yet the molecular drivers governing lymphatic dissemination remain poorly characterized. Integrating single-cell transcriptomic profiling with Mendelian-randomization (MR)-based genetic prioritization may help reveal cell type-specific mechanisms underlying metastatic progression.MethodsWe analyzed the GSE195861 single-cell RNA sequencing dataset encompassing six invasive ductal carcinoma (IDC) samples and paired ALNM specimens. t-distributed Stochastic Neighbor Embedding-based clustering and SingleR annotation delineated cellular heterogeneity, while differential expression analysis identified metastasis-associated genes in epithelial compartments. MR analysis employing five robust methods (inverse variance-weighted, weighted median, MR-Egger, simple/weighted mode) integrated genome-wide association study data (GCST90018799) to establish causal gene-breast cancer associations. CellChat reconstructed ligand-receptor networks across nine annotated cell types.ResultsUnsupervised clustering resolved 27 cell clusters into nine lineages, revealing ALNM-specific expansion of monocytes, pre-B cells, and CD34+ hematopoietic stem cells (HSCs). Epithelial cells exhibited 2421 differentially expressed genes (DEGs) between IDC and ALNM, including 12 genes whose genetically predicted expression showed significant associations with breast cancer risk in MR analysis (P < 0.05). CD53 (odds ratio (OR) = 1.110, 95% confidence interval (CI) = 1.019-1.209, P = 0.017) and TCDD-inducible poly-ADP-ribose polymerase (TIPARP) (OR = 1.153, 95% CI = 1.032-1.288, P = 0.012) were prioritized as candidate genes, as their genetically predicted expression was associated with increased breast cancer risk in weighted median MR. Cell-cell communication analysis implicated macrophage-derived midkine-nucleolin signaling and B-cell-orchestrated macrophage migration inhibitory factor-(CD74 + CXCR4) axis in metastatic crosstalk. Functional enrichment linked DEGs to extracellular matrix remodeling and MAPK/PI3K-Akt activation.ConclusionThis multi-omics integration prioritizes CD53 and TIPARP as ALNM-associated candidate genes with genetically supported associations with breast cancer risk, with macrophage-epithelial and B-cell-HSC interactions serving as potential therapeutic targets. Our findings provide a roadmap for developing metastasis-interceptive strategies through precision targeting of the ALNM-associated tumor microenvironment.</p>","PeriodicalId":50334,"journal":{"name":"International Journal of Biological Markers","volume":" ","pages":"3936155261443650"},"PeriodicalIF":2.0,"publicationDate":"2026-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147934972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circulating tumor DNA: An alternative to tissue biopsy for detecting epidermal growth factor receptor mutation in non-small cell lung cancer. 循环肿瘤DNA:用于检测非小细胞肺癌表皮生长因子受体突变的组织活检的替代方法。
IF 2 4区 医学
International Journal of Biological Markers Pub Date : 2026-04-26 DOI: 10.1177/03936155261445461
Md Kabirul Islam Soroar, Sharmistha Roy, Hosne Ara, Sharif Al Nur, Riyadh Arifin Akanda, Mohammad Masum Alam
{"title":"Circulating tumor DNA: An alternative to tissue biopsy for detecting epidermal growth factor receptor mutation in non-small cell lung cancer.","authors":"Md Kabirul Islam Soroar, Sharmistha Roy, Hosne Ara, Sharif Al Nur, Riyadh Arifin Akanda, Mohammad Masum Alam","doi":"10.1177/03936155261445461","DOIUrl":"https://doi.org/10.1177/03936155261445461","url":null,"abstract":"<p><p>BackgroundNon-small cell lung cancer (NSCLC) patients who have mutations in their epidermal growth factor receptor (<i>EGFR</i>) gene respond more favorably to tyrosine kinase inhibitors (TKIs) than to standard chemotherapy. However, tissue biopsy-based <i>EGFR</i> testing is invasive, costly, and technically challenging. Plasma-derived circulating tumor DNA (ctDNA) offers a minimally invasive and cost-efficient alternative for mutation profiling. This study assessed the agreement between <i>EGFR</i> mutation status in plasma-derived ctDNA and tissue biopsy in NSCLC patients from tertiary care hospitals in Bangladesh.MethodsIn this cross-sectional analytical study, we recruited 32 patients with NSCLC before EGFR-TKI treatment. <i>EGFR</i> mutations in ctDNA samples were identified using the Amplification Refractory Mutation System (ARMS) polymerase chain reaction method. Tissue biopsy results were obtained from routine diagnostic procedures. Agreement between ctDNA and tissue biopsy results was assessed using kappa statistics, and diagnostic performance metrics were calculated.ResultsMost of our study participants were male (75%) and had stage IV lung adenocarcinoma (72%). We observed substantial agreement between plasma-derived ctDNA samples and tissue biopsies (kappa, κ = 0.683). This agreement was almost perfect (κ = 0.826) when calculated for patients with stage IV disease. The overall concordance was 84.4%. Compared with tissue biopsy, ctDNA testing yielded a sensitivity of 73.3% and a specificity of 94.1%.ConclusionPlasma-derived ctDNA demonstrates substantial agreement with tissue biopsy for <i>EGFR</i> mutation detection in patients with NSCLC, particularly those with advanced-stage disease. These findings support ctDNA as a viable alternative for molecular profiling in settings where tissue biopsy is limited or impractical.</p>","PeriodicalId":50334,"journal":{"name":"International Journal of Biological Markers","volume":" ","pages":"3936155261445461"},"PeriodicalIF":2.0,"publicationDate":"2026-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147787914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single-cell RNA sequencing analysis reveals cellular heterogeneity and immune microenvironment dynamics in colorectal cancer. 单细胞RNA测序分析揭示结直肠癌的细胞异质性和免疫微环境动力学。
IF 2 4区 医学
International Journal of Biological Markers Pub Date : 2026-04-12 DOI: 10.1177/03936155261441324
Jin-Liang Zhu, Hong-Jian Gao, Lu-Ji Qiao, Rong-Xiang Si, Xing-Dong Li, Yi You, Zhi-Tao Yin
{"title":"Single-cell RNA sequencing analysis reveals cellular heterogeneity and immune microenvironment dynamics in colorectal cancer.","authors":"Jin-Liang Zhu, Hong-Jian Gao, Lu-Ji Qiao, Rong-Xiang Si, Xing-Dong Li, Yi You, Zhi-Tao Yin","doi":"10.1177/03936155261441324","DOIUrl":"https://doi.org/10.1177/03936155261441324","url":null,"abstract":"<p><p>BackgroundDespite treatment advances, prognoses of patients with advanced colorectal cancer remain poor. The limited effectiveness of programmed cell death protein 1 (PD-1) blockade immunotherapy in a subset of patients necessitates a deeper understanding of the colorectal cancer microenvironment. This study aimed to identify new therapeutic targets and potential biomarkers by investigating CD8 <sup>+</sup> CD101hiTim3<sup>+</sup> (CCT) T cells and their progenitors in colorectal cancer, and their association with immunotherapy response at the transcriptomic level.MethodsWe used single-cell sequencing data and The Cancer Genome Atlas database for comprehensive bioinformatics analysis, including single-cell sequencing data analysis, Gene Set Variation Analysis, pseudotime analysis, cell communication analysis, and construction and validation of a prognostic model.ResultsKey findings include the identification and annotation of various T-cell subtypes in colorectal cancer, construction of a pseudotime trajectory of CCT T cells and their progenitors showing dynamic gene expression changes, and enhanced interactions between CCT T cell progenitors and other cells in the PD-1 immunotherapy group. We developed and validated a prognostic model comprising 15 gene features with strong prognostic stratification performance, revealing that high-risk patients exhibit transcriptomic associations with potentially reduced responses to immune checkpoint inhibitors (ICIs). Pathway enrichment analysis highlighted critical pathways, including leukocyte adhesion and T cell activation, indicating complex influences on disease progression and treatment responses within the colorectal cancer immune landscape.ConclusionsThis study emphasizes the potential importance of targeted therapies that modulate immune interactions and functional states to improve colorectal cancer prognosis, particularly in high-risk patients who show an association at the transcriptomic level with reduced ICI responsiveness.</p>","PeriodicalId":50334,"journal":{"name":"International Journal of Biological Markers","volume":" ","pages":"3936155261441324"},"PeriodicalIF":2.0,"publicationDate":"2026-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147678368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BDH1 drives ovarian cancer progression by regulating cell cycling and stemness maintenance through Wnt/β-catenin signaling. BDH1通过Wnt/β-catenin信号传导调节细胞周期和干细胞维持,从而驱动卵巢癌的进展。
IF 2 4区 医学
International Journal of Biological Markers Pub Date : 2026-03-26 DOI: 10.1177/03936155261435599
Shujing Sun, Lianghui Guo, Huili Zhu
{"title":"BDH1 drives ovarian cancer progression by regulating cell cycling and stemness maintenance through Wnt/β-catenin signaling.","authors":"Shujing Sun, Lianghui Guo, Huili Zhu","doi":"10.1177/03936155261435599","DOIUrl":"https://doi.org/10.1177/03936155261435599","url":null,"abstract":"<p><p>BackgroundOvarian cancer is a lethal malignancy with limited therapeutic options, highlighting the urgent need to identify reliable biomarkers and therapeutic targets. This study investigates the clinical and oncogenic significance of β-hydroxybutyrate dehydrogenase 1 (BDH1) as a potential therapeutic target in ovarian cancer.MethodsIntegrative genomic analyses were conducted to evaluate the oncogenic potential of BDH1 by assessing its gene amplification and expression patterns in ovarian cancer. Functional assays, including BDH1 knockdown, were performed to examine its effects on proliferation, colony formation, cell cycle, and stemness. Mechanism exploration involved assessing the Wnt/β-catenin pathway. Virtual screening was used to identify BDH1 inhibitors.ResultsBDH1 was identified as a crucial oncogene in ovarian cancer progression, characterized by frequent gene amplification and overexpression, which strongly correlated with advanced disease stage and poor patient prognosis. Functionally, BDH1 promoted tumor progression by regulating G1/S transition proteins and maintaining cancer stemness via Wnt/β-catenin signaling. BDH1 depletion suppressed malignant phenotypes, confirming its oncogenic role. BDH1 was pharmacologically targeted by centrinone, which effectively downregulated oncogenic effectors.ConclusionOur study underscores BDH1 as a multifunctional oncogenic driver in ovarian cancer. The strong association of BDH1 with aggressive disease underscores its clinical relevance as a prognostic predictor, while its functional role and pharmacological inhibition position BDH1 as a promising therapeutic target for ovarian cancer.</p>","PeriodicalId":50334,"journal":{"name":"International Journal of Biological Markers","volume":" ","pages":"3936155261435599"},"PeriodicalIF":2.0,"publicationDate":"2026-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147516503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phosphorylated DHX9 inhibited the progression of lung adenocarcinoma by regulating R-loops mediated DNA damage. 磷酸化的DHX9通过调节r环介导的DNA损伤来抑制肺腺癌的进展。
IF 2 4区 医学
International Journal of Biological Markers Pub Date : 2026-03-20 DOI: 10.1177/03936155261433188
Lei Wu, Shengyu Wang, Xin Diao, Xuan Ma, Yanfeng Liu
{"title":"Phosphorylated DHX9 inhibited the progression of lung adenocarcinoma by regulating R-loops mediated DNA damage.","authors":"Lei Wu, Shengyu Wang, Xin Diao, Xuan Ma, Yanfeng Liu","doi":"10.1177/03936155261433188","DOIUrl":"https://doi.org/10.1177/03936155261433188","url":null,"abstract":"<p><p>ObjectivesWe investigated the interactions among DHX9, phosphorylated DHX9, R-loops, and DNA damage to clarify the mechanism by which phosphorylated DHX9 inhibited lung adenocarcinoma progression.MethodsUsed PC-9 and 2BS cells divided into control, siDHX9, OE-DHX9, siDHX9 + OE-RNase H1, OE-PKA, DHX9-S279A, 6-22 Amide, and DHX9-S279A + OE-RNase H1 groups. Assays included quantitative real-time polymerase chain reaction (qRT-PCR), WB (DHX9, γH2AX, Rad51, pCtIP), EdU/CCK-8 (proliferation), TUNEL/flow cytometry (apoptosis), comet assay (DNA damage), CldU/IdU (replication), DRIP-qPCR (R-loops). Nude mice xenografts (control, siDHX9, DHX9-S279E, DHX9-S279A) assessed tumor growth, Ki67, R-loops, DNA damage, and replication.ResultsDHX9 was highly expressed in multiple cancer tissues and lung cancer cell lines, with higher messenger RNA levels in PC-9 than in 2BS cells. Compared with PC-9, siDHX9 reduced proliferation and increased apoptosis, while OE-DHX9 exerted opposite effects. siDHX9 increased DNA damage (with corresponding changes in γH2AX, Rad51, and pCtIP levels), reduced replication (rescued by OE-RNase H1), and elevated R-loops; OE-DHX9 showed opposite effects on damage and R-loops. OE-PKA increased R-loops and damage, and reduced replication, while DHX9-S279A or 6-22 Amide decreased these and 6-22 Amide also increased replication versus PC-9/OE-PKA. DHX9-S279A increased proliferation, with DHX9-S279A + OE-RNase H1 further enhancing this and reducing apoptosis. In vivo, siDHX9 and DHX9-S279E reduced tumor volume/mass and Ki67, increased R-loops, damage, and γH2AX/Rad51/pCtIP, and inhibited replication; DHX9-S279A showed opposite effects versus these groups, with no significant tumor difference versus PC-9 and higher replication versus both.ConclusionsPhosphorylated DHX9 might enhance DNA damage by suppressing R-loop resolution, ultimately inhibiting the proliferation of lung adenocarcinoma cells.</p>","PeriodicalId":50334,"journal":{"name":"International Journal of Biological Markers","volume":" ","pages":"3936155261433188"},"PeriodicalIF":2.0,"publicationDate":"2026-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147488228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HPV-positive head and neck squamous cell carcinoma: From molecular pathogenesis to therapeutic frontiers. hpv阳性头颈部鳞状细胞癌:从分子发病机制到治疗前沿。
IF 2 4区 医学
International Journal of Biological Markers Pub Date : 2026-03-07 DOI: 10.1177/03936155261428136
Ying Li, Shengfei Zhou
{"title":"HPV-positive head and neck squamous cell carcinoma: From molecular pathogenesis to therapeutic frontiers.","authors":"Ying Li, Shengfei Zhou","doi":"10.1177/03936155261428136","DOIUrl":"https://doi.org/10.1177/03936155261428136","url":null,"abstract":"<p><p>The global incidence of human papillomavirus (HPV)-positive head and neck squamous cell carcinoma (HNSCC) has increased markedly over recent decades, leading to a fundamental shift in the epidemiology and clinical management of head and neck malignancies. HPV-positive HNSCC represents a biologically and clinically distinct disease entity, characterized by unique molecular features, improved treatment responsiveness, and a more favorable prognosis compared with HPV-negative tumors. However, the optimal integration of molecular insights with evolving therapeutic strategies remains an ongoing clinical and translational challenge. In this review, we summarize the etiological role of HPV in the pathogenesis of HNSCC and delineate key differences in epidemiology, molecular biology, and clinical presentation between HPV-positive and HPV-negative disease. We further examine current standard-of-care treatments, including surgery, radiotherapy, and chemotherapy, with particular emphasis on de-escalation strategies aimed at reducing long-term toxicity while maintaining oncologic efficacy in HPV-positive patients. Emerging immunotherapeutic approaches have demonstrated encouraging activity in recurrent or metastatic disease. Moreover, therapeutic vaccine development, including DNA-, mRNA-, peptide-, and viral vector-based platforms targeting HPV E6/E7 oncoproteins, represents a rapidly evolving area with the potential to enhance antitumor immunity. This review also highlights ongoing clinical trials that may reshape the future landscape of treatment for HPV-positive HNSCC. Collectively, these advances emphasize the importance of HPV status in guiding personalized management strategies and improving patient outcomes.</p>","PeriodicalId":50334,"journal":{"name":"International Journal of Biological Markers","volume":" ","pages":"3936155261428136"},"PeriodicalIF":2.0,"publicationDate":"2026-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147370603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meta-analytic and systematic review of the diagnostic value of DNA methylation-based biomarkers in cervical cancer. DNA甲基化生物标志物在宫颈癌诊断价值的荟萃分析和系统评价。
IF 2 4区 医学
International Journal of Biological Markers Pub Date : 2026-03-05 DOI: 10.1177/03936155261419529
Hue Hong Thieu, Thuy Ai Huyen Le, Thuan Duc Lao
{"title":"Meta-analytic and systematic review of the diagnostic value of DNA methylation-based biomarkers in cervical cancer.","authors":"Hue Hong Thieu, Thuy Ai Huyen Le, Thuan Duc Lao","doi":"10.1177/03936155261419529","DOIUrl":"https://doi.org/10.1177/03936155261419529","url":null,"abstract":"<p><p>IntroductionCervical cancer represents a significant global health problem, ranking as the fourth most prevalent malignant cancer in women, particularly in low- and middle-income countries. Epigenetic silencing via aberrant methylation of tumor suppressor genes' promoters represent a second hit of cancer initializing, as well as progressing. The aim of current meta-analysis was to systematically evaluate the potential of DNA methylation-based biomarkers in non-invasive or minimal invasive samples using molecular-based approaches for cervical cancer screening and diagnosis.MethodsThe Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guideline was applied to perform our meta-analysis. The frequency, odds ratios, sensitivity as well as specificity with the corresponding 95% confidence intervals were used to assess the effect sizes.ResultsThere were 20 eligible articles ultimately included in the current meta-analysis. In this meta-analysis, multiple tumor suppressor genes, such as, especially, <i>PAX1, SOX1, CDO1, GHSR,</i> were shown to undergo hypermethylation in cervical cancer samples compared with controls. Urine samples, when combined with MSP- and qMSP-based approaches, emerged as a particularly effective non-invasive strategy.ConclusionThe current meta-analysis highlighted the important steps toward establishing DNA-methylation-based biomarkers as accessible and reliable tools for CC screening and diagnosis.</p>","PeriodicalId":50334,"journal":{"name":"International Journal of Biological Markers","volume":" ","pages":"3936155261419529"},"PeriodicalIF":2.0,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147357427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Causal association between oxidative stress and lymphomas: A two-sample Mendelian randomization study. 氧化应激与淋巴瘤之间的因果关系:一项双样本孟德尔随机研究。
IF 2 4区 医学
International Journal of Biological Markers Pub Date : 2026-03-02 DOI: 10.1177/03936155261428137
Bin Zhu, Wenli Zhao
{"title":"Causal association between oxidative stress and lymphomas: A two-sample Mendelian randomization study.","authors":"Bin Zhu, Wenli Zhao","doi":"10.1177/03936155261428137","DOIUrl":"https://doi.org/10.1177/03936155261428137","url":null,"abstract":"<p><p>ObjectivesTo explore the causal associations between oxidative stress markers and the occurrence of various types of lymphomas.MethodsThis two-sample Mendelian randomization (MR) study employed summary data from genome-wide association studies of oxidative stress markers and various lymphoma types. Analysis was conducted using the inverse variance weighted, with confirmation using the weighted median, weighted mode, and MR-Egger regression methods. Heterogeneity, horizontal pleiotropy, outliers, and robustness were tested using the Cochran Q, MR-Egger regression, MR pleiotropy residual sum and outlier (MR-PRESSO), and leave-one-out methods.ResultsGenetically predicted myeloperoxidase (MPO) was causally associated with follicular lymphoma (odds ratio (OR) = 1.33, <i>P</i> = 0.0173). Uric acid showed a causal link to diffuse large B-cell lymphoma (DLBCL) (OR = 1.003, <i>P</i> = 0.043). Glutathione peroxidase (GPX) was associated with follicular lymphoma (OR = 1.16, <i>P</i> = 0.033). Catalase (CAT) was inversely associated with non-Hodgkin lymphoma (NHL) (OR = 0.8921), non-follicular lymphoma (OR = 0.8755), and follicular lymphoma (OR = 0.8364) (all <i>P</i> < 0.05). Glutathione-S transferase (GST) was inversely associated with NHL (OR = 0.9248) and follicular lymphoma (OR = 0.8313) (all <i>P </i>< 0.05). Heterogeneity was noted for uric acid and DLBCL, but no pleiotropy was detected; after outlier removal, the association with uric acid was non-significant.ConclusionsThe findings suggest causal relationships between oxidative stress markers and lymphoma risk, notably MPO and GPX with follicular lymphoma, and inverse associations for GST and CAT with different lymphoma types. Limitations include heterogeneity for some markers, requiring further validation.</p>","PeriodicalId":50334,"journal":{"name":"International Journal of Biological Markers","volume":" ","pages":"3936155261428137"},"PeriodicalIF":2.0,"publicationDate":"2026-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147345594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LINC00578 as a prognostic biomarker in lung adenocarcinoma via regulation of miR-153-5p. LINC00578通过调节miR-153-5p作为肺腺癌的预后生物标志物。
IF 2 4区 医学
International Journal of Biological Markers Pub Date : 2026-03-02 DOI: 10.1177/03936155261417698
Wenju Pan, Jun Hong, Mingwei Zhang, Sumeng Wang, Xin Lu, Tingting Ji, Jing Zhang, Yaoman Guo
{"title":"LINC00578 as a prognostic biomarker in lung adenocarcinoma via regulation of miR-153-5p.","authors":"Wenju Pan, Jun Hong, Mingwei Zhang, Sumeng Wang, Xin Lu, Tingting Ji, Jing Zhang, Yaoman Guo","doi":"10.1177/03936155261417698","DOIUrl":"https://doi.org/10.1177/03936155261417698","url":null,"abstract":"<p><p>BackgroundLung adenocarcinoma (LUAD) remains one of the leading causes of cancer-related deaths worldwide, with limited therapeutic efficacy despite advances in treatment. Our study investigated the role of LINC00578 and its regulatory interaction with miR-153-5p in LUAD progression.MethodsThe expression levels of LINC00578 and miR-153-5p were assessed in LUAD tissues and adjacent normal tissues using quantitative real-time polymerase chain reaction. Associations between LINC00578 expression and clinicopathological features and patient prognosis were analyzed. Luciferase reporter assays, proliferation, migration, invasion, and apoptosis analyses, were conducted in LUAD cell lines (PC-9 and H1299) following modulation of LINC00578 and miR-153-5p expression.ResultsLINC00578 was significantly upregulated in LUAD tissues compared to adjacent normal tissues, whereas miR-153-5p was markedly downregulated. High LINC00578 expression was associated with lymph node metastasis, tumor-node-metastasis stage, and poor overall survival. Functional studies revealed that silencing LINC00578 inhibited LUAD cell proliferation, migration, and invasion while promoting apoptosis. Mechanistically, LINC00578 exerted its oncogenic effects by negatively regulating miR-153-5p expression. Inhibition of miR-153-5p reversed the tumor-suppressive effects induced by LINC00578 knockdown.ConclusionLINC00578 functions as an oncogenic long non-coding RNA in LUAD by promoting proliferation and metastasis through suppression of miR-153-5p. LINC00578 may serve as a novel prognostic biomarker for LUAD.</p>","PeriodicalId":50334,"journal":{"name":"International Journal of Biological Markers","volume":" ","pages":"3936155261417698"},"PeriodicalIF":2.0,"publicationDate":"2026-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147345626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The European Organisation for Research and Treatment of Cancer Pathobiology group and the young task force: A pan-tumor framework for translational oncology. 欧洲癌症病理生物学研究和治疗组织和青年工作组:转化肿瘤学的泛肿瘤框架。
IF 2 4区 医学
International Journal of Biological Markers Pub Date : 2026-03-02 DOI: 10.1177/03936155261428482
Daria Maria Filippini, Johannes Haybaeck
{"title":"The European Organisation for Research and Treatment of Cancer Pathobiology group and the young task force: A pan-tumor framework for translational oncology.","authors":"Daria Maria Filippini, Johannes Haybaeck","doi":"10.1177/03936155261428482","DOIUrl":"https://doi.org/10.1177/03936155261428482","url":null,"abstract":"<p><p>Progress in precision oncology depends on effective and well-coordinated collaboration between pre-clinical researchers and clinical investigators. In this setting, the European Organisation for Research and Treatment of Cancer (EORTC) Pathobiology group (PBG) plays a key role in reinforcing the link between biological research and clinical investigation, facilitating the translation of biological and medical findings into clinical application, supporting the rigorous testing of molecular hypotheses in clinical trials, and providing multidisciplinary expertise for biomarker development and validation across different tumor types. A defining characteristic of the EORTC PBG is its pan-tumor perspective, which is consistent with the evolving molecular taxonomy of cancer and, through specialized expertise in molecular biology, pathology, biomarker development, and quality assurance, contributes to the activities of both the EORTC Translational Research Division and the Disease-Oriented Groups. This editorial outlines the scientific mission and achievements of the EORTC PBG, highlights the increasing contribution of Young and Early Career Investigators within the group, and emphasizes the importance of pathobiology-driven research in rare cancers, where unmet clinical needs remain considerable.</p>","PeriodicalId":50334,"journal":{"name":"International Journal of Biological Markers","volume":" ","pages":"3936155261428482"},"PeriodicalIF":2.0,"publicationDate":"2026-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147328005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书